Both ProTα-EGFP release and ANXA2 externalization in C6 glioma cells were significantly inhibited by the addition of ω-conotoxin (ω-CTX) GVIA, an N-type voltage-dependent Ca2+ channel inhibitor (Figure 2C). The gene discussed is ANXA2; the disease is central nervous system cancer.